Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 07, 2025

BUY
$4.14 - $15.3 $92,214 - $340,792
22,274 New
22,274 $100,000
Q2 2024

Dec 03, 2024

BUY
$4.14 - $15.3 $92,214 - $340,792
22,274 New
22,274 $100,000
Q2 2024

Aug 14, 2024

BUY
$4.14 - $15.3 $92,214 - $340,792
22,274 New
22,274 $100,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $123M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.